Neurocrine Biosciences reported $21.4M in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Amgen AMGN:US $ 2727M 56M
Biogen BIIB:US $ 903.4M 316.6M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Cytokinetics CYTK:US $ -86.75M 56.18M
Dynavax Technologies DVAX:US $ 32.86M 67.73M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.44M
Exelixis EXEL:US $ 85.23M 32.79M
Halozyme Therapeutics HALO:US $ 81.63M 20.43M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
IONIS PHARMACEUT IONS:US $ -64M 289M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Pfizer PFE:US $ 11328M 4083M
Prothena PRTA:US $ -37.96M 4.86M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Repligen RGEN:US $ 66.75M 10.48M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.74M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Teva Pharmaceutical TEVA:IT -971000000 796M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Xoma XOMA:US $ -2.28M 32.22M
YTE INCY:US $ 172.84M 1.75M